Erratum: Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis (PLoS ONE (2014) 9:8 (e104158) (DOI:10.1371/journal.pone.0104158));Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Mah, Way Champ ^b,c   Thurnherr, Thomas ^c,d   Chow, Pierce K H ^d,e   Chung, Alexander Y F ^e   Ooi, London L P J ^b,e   Toh, Han Chong ^b   Teh, Bin Tean ^b,d,f   Saunthararajah, Yogen ^g   Lee, Caroline G L ^a,b,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; PROTEIN FUNCTION; PYROSEQUENCING; SIGNAL TRANSDUCTION; SINGAPORE; SURVIVAL TIME; CLASSIFICATION; CLUSTER ANALYSIS; DNA METHYLATION; DNA SEQUENCE; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CLUSTER ANALYSIS; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

EID: 84905647853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146690     Document Type: Erratum

References (55)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA-Cancer J Clin 61: 69-90.
2. Yuen MF, Hou JL, Chutaputti A (2009) Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 24: 346-353.
3. Minouchi K, Kaneko S, Kobayashi K (2002) Mutation of p53 gene in regenerative nodules in cirrhotic liver. J Hepatol 37: 231-239. (Pubitemid 34833085)
4. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431. (Pubitemid 21912246)
5. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, et al. (2004) Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 24: 1077-1083.
6. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, et al. (2003) Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 106: 334-341. (Pubitemid 36870393)
7. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, et al. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250. (Pubitemid 30132191)
8. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, et al. (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21: 4863-4871. (Pubitemid 34879463)
9. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44: 694-698.
10. Nishida N, Goel A (2011) Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 12: 130-137.
11. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, et al. (2003) Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 13: 319-333. (Pubitemid 43231848)
12. Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E (2003) p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett 190: 213-219. (Pubitemid 36136020)
13. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, et al. (2003) Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-1378. (Pubitemid 37175085)
14. Yang B, Guo M, Herman JG, Clark DP (2003) Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163: 1101-1107. (Pubitemid 37040145)
15. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, et al. (2011) Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 71: 5891-5903.
16. Shitani M, Sasaki S, Akutsu N, Takagi H, Suzuki H, et al. (2012) Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumor Biol 33: 1307-1317.
17. Shen J,Wang S, Zhang YJ, Kappil M, Wu HC, et al. (2012) Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 55: 1799-1808.
18. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, et al. (2010) Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 5: e9749.
19. Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, et al. (2013) Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 8: 34-43.
20. Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, et al. (2013) Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One 8: e55761.
21. Tao R, Li J, Xin J, Wu J, Guo J, et al. (2011) Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS One 6: e19862.
22. Ammerpohl O, Pratschke J, Schafmayer C, Haake A, Faber W, et al. (2012) Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 130: 1319-1328.
23. Archer KJ, Mas VR, Maluf DG, Fisher RA (2010) High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics 283: 341-349.
24. Sung WK, Lu Y, Lee CW, Zhang D, Ronaghi M, et al. (2009) Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. The Journal of biological chemistry 284: 21941-21954.
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T) (-Delta Delta C) method. Methods 25: 402-408. (Pubitemid 34164012)
26. Carlson M, Falcon S, Pages H, Li N. lumiHumanAll.db: me Human Illumina annotation data (chip lumiHumanAll). R package version 1.18.0.
27. Du P, Feng G, Kibbe W, Lin S. lumiHumanIDMapping: Illumina Identifier mapping for Human R package version 1.10.0.
28. Carlson M. hgug4112a.db: Agilent "Human Genome, Whole" annotation data (chip hgug4112a). R package version 2.8.0.
29. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127. (Pubitemid 44906106)
30. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
31. Monti S, Tamayo P, Mesirov J, Golub T (2003) Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning 52: 91-118.
32. Lei Z, Tan IB, Das K, Deng N, Zouridis H, et al. (2013) Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 145: 554-565.
33. Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26: 1572-1573.
34. Lee HP, Chew L, Chow KY, Jin A, Loy EY, et al. (2013) Singapore cancer registry interim annual registry report: trends in cancer incidence in Singapore 2007-2011. Singapore: National Registry of Diseases Office. pp. 9-16.
35. Di Bisceglie AM (2009) Hepatitis B and hepatocellular carcinoma. Hepatology 49: S56-S60.
36. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, et al. (2011) Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 3: 75ra25.
37. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862. (Pubitemid 41077111)
38. Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, et al. (2012) Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res 22: 1197-1211.
39. Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, et al. (2012) Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med 4: 156ra140.
40. Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, et al. (2005) Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 221: 135-143. (Pubitemid 40460400)
41. Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, et al. (2003) Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Cancer Res 63: 8674-8679. (Pubitemid 38064043)
42. Tung EK, Wong CM, Yau TO, Lee JM, Ching YP, et al. (2009) HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions. International journal of cancer Journal international du cancer 124: 1811-1819.
43. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
44. Ebert MP, Model F, Mooney S, Hale K, Lograsso J, et al. (2006) Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology 131: 1418-1430. (Pubitemid 44708938)
45. Fatemi M, Paul TA, Brodeur GM, Shokrani B, Brim H, et al. (2014) Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages. Cancer 120: 172-180.
46. Hiranuma C, Kawakami K, Oyama K, Ota N, Omura K, et al. (2004) Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer. Int J Mol Med 13: 413-417.
47. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, et al. (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106: 1110-1118.
48. Lee CK, Lee JH, Lee MG, Jeong SI, Ha TK, et al. (2010) Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors. BMC Cancer 10: 1471-2407.
49. Um TH, Kim H, Oh BK, Kim MS, Kim KS, et al. (2011) Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 54: 939-947.
50. Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, et al. (2008) Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 29: 1901-1910.
51. Mah WC, Lee CG (2014) DNA methylation: potential biomarker in Hepatocellular Carcinoma. Biomark Res 2: 5.
52. Karin M (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1.
53. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, et al. (2009) Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 1155: 206-221.
54. Suzuki H, Toyota M, Kondo Y, Shinomura Y (2009) Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome. Methods Mol Biol 512: 55-69.
55. Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, et al. (2014) Hepatitis virus infection affects DNA methylation in mice with humanized livers. Gastroenterology 146: 562-572.